Prevalence of Obstructive Sleep Apnea Syndrome in Sarcoidosis and Impact of CPAP Treatment on Associated Fatigue Status

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 27, 2019

Primary Completion Date

May 15, 2019

Study Completion Date

July 30, 2019

Conditions
SarcoidosisSleep Apnea, ObstructiveFatigue
Interventions
DEVICE

Continuous Positive Airway Pressure (CPAP)

Continuous positive airway pressure (CPAP) is the gold standard for Obstructive Sleep Apnea Syndrome (OSAS) management when moderate-to-severe. Subjects with OSA will be trained in the use of CPAP and will be instructed to use it every night for 3 months. These subjects will then return for a post-treatment completion of questionnaires (ESS and FAS) and compliance analysis.

Trial Locations (1)

00168

Policlinico Universitario Agostino Gemelli, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT03926832 - Prevalence of Obstructive Sleep Apnea Syndrome in Sarcoidosis and Impact of CPAP Treatment on Associated Fatigue Status | Biotech Hunter | Biotech Hunter